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ABSTRACT
Understanding the relationship between adverse exposure events and specific material properties will facilitate
predictive classification of carbon nanotubes (CNTs) according to their mechanisms of action, and a safe-by-
design approach for the next generation of CNTs. Mass-spectrometry-based proteomics is a reliable tool to
uncover the molecular dynamics of hazardous exposures, yet challenges persist with regards to its limited
dynamic range when sampling whole organisms, tissues or cell lysates. Here, the simplicity of the sub-cellular
proteome was harnessed to unravel distinctive adverse exposure outcomes at the molecular level, between two
CNT subtypes. A549, MRC9 and human macrophage cells, were exposed for 24h to non-cytotoxic doses of
single-walled or multi-walled CNTs (swCNTs or mwCNTs). Label-free proteomics on enriched cytoplasmic
fractions was complemented with analyses of reactive oxygen species (ROS) production and mitochondrial
integrity. The extent/number of modulated proteoforms indicated the single-walled variant was more
bioactive. Greater enrichment of pathways corresponding to oxido-reductive activity was consistent with
greater intracellular ROS induction and mitochondrial dysfunction capacities of swCNTs. Other compromised
cellular functions, as revealed by pathway analysis were; ribosome, spliceosome and DNA repair. Highly
upregulated proteins (fold change in abundance > 6) such as, APOC3, RBP4 and INS are also highlighted as
potential markers of hazardous CNT exposure. We conclude that, changes in cytosolic proteome abundance
resulting from nano-bio interactions, elucidate adverse response pathways and their distinctive molecular
components. Our results indicate that CNT-protein interactions might have a thus far unappreciated
significance for protein trafficking, and this warrants further investigation.
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INTRODUCTION
Carbon nanotubes (CNTs) are a class of engineered nanomaterials (ENMs) that have been used in the last
decade to develop applications with tremendous and promising impact in industry and medicine (De Volder
et al. 2013; Sharma et al. 2015). They are tubular structures consisting of one (single-walled carbon nanotubes
– swCNTs) or more (multi-walled carbon nanotubes – mwCNTs) concentric graphene cylinders. The fiber-
like conformation and biodurability of rod-like CNTs are stark parallels to the infamous asbestos fibers,
fueling concerns that CNTs may be harmful to the human health. Several studies in rodents reveal common
pathophysiological responses following CNT or asbestiform fiber exposures, which include acute-phase
inflammation, granuloma formation and development of fibrosis (Muller et al. 2005; Shvedova et al. 2005;
Shvedova et al. 2008; Ma-Hock et al. 2009). According to the fiber pathogenicity paradigm, (Donaldson et al.
2013) CNT toxicity is thought to be largely mediated by its morphology and biopersistence, whereas its
chemical composition plays a lesser role. This differential bioactivity of chemically similar ENMs was further
explained by studies showing that, once a nanomaterial is within a physiological environment, it adsorbs
proteins forming a protein corona – the composition of which reflects the nature of that environment (plasma,
cell cytoplasm, respiratory tract, etc.), the nanomaterial’s physicochemical attributes (size, shape, surface
chemistry, etc.) and the duration of exposure (Lundqvist 2013; Monopoli et al. 2012). In other words, this
eventual biological identity of a nanomaterial dictates the physiological responses it elicits, including but not
limited to; transport, kinetics, accumulation, signaling and ultimately, toxicity (Cedervall et al. 2007; Sund et
al. 2011; Byrne et al. 2013). We previously reported differential protein binding and cellular uptake between
short mwCNT and short swCNT subtypes (Sund et al. 2011). The objectives of the current study were to
investigate the implications of this differential protein interaction between these two CNT subtypes at the
systemic level. Because aerosolized CNT levels of up to 331 µg/m3 and 430 µg/m3 have been measured in
industry (Siegrist et al. 2014) and in a laboratory setting (Manke et al. 2014) respectively, inhalation is a highly
relevant exposure scenario. Here, we used three cell types; human monocyte-derived macrophages – to reflect
the first line of defense against foreign materials and human lung fibroblast (MRC9)/lung epithelia (A549)
cell lines – to mimic the exposure route (respiratory tract lining) to CNT aerosols. We hypothesized that due
to the inevitable interaction of cytoplasmic proteins and CNTs once they are taken up by cells, proteomic
characterization of enriched cytoplasmic fractions will provide a simple and effective way to identify material-
specific health hazard biomarkers. Selected canonical pathways that were identified as differentially
susceptible to these two CNT subtypes were then validated using standard assays.
MATERIALS AND METHODS
Nanomaterials
(Short) S-Purified single-walled and S-Purified multi-walled CNTs were obtained commercially (SES
Research, Houston, TX, USA). Crocidolite asbestos was provided by Pneumoconiosis Research Centre
(Johannesburg, South Africa) and Carbon black (Printex 90) was a gift from Evonik Industries AG (Essen,
Germany). Characterization and dispersion protocols for these materials have been established in-house and
previously described; mwCNT and swCNT (Sund et al. 2011; Catalán et al. 2012), asbestos crocidolite and
carbon black (Palomäki et al. 2011). In the current study, size distribution and zeta potential characterization
of 1 mg/ml nanomaterial suspensions in cell culture media containing 10% FBS were carried out for CNTs as
described previously (Sund et al. 2011).
Cell models and growth conditions
Human lung epithelia – A549, human lung fibroblasts – MRC9 (both cell lines from ATCC, Manassas, VA,
USA) and human monocyte-derived macrophages (MDM) were used for exposures. Human MDM were
differentiated from peripheral blood mononuclear cells (PBMCs) obtained from healthy blood donors (The
Finnish Red Cross Blood Transfusion Service, Helsinki, Finland). The differentiation was performed by
isolating peripheral blood mononuclear cells from buffy coats by Ficoll-Paque Plus - gradient low-speed
centrifugation as described previously (Sund et al. 2011). The macrophage medium was changed every two
days. Maturated macrophages are used for exposure studies on the seventh day. Epithelial cells (A549) and
lung fibroblasts (MRC9) were both cultured in DMEM containing 2 mM L-glutamine supplemented with 10
% of heat inactivated FBS and 1% PEST antibiotics. MRC9 culture medium was additionally supplemented
with 1% L-Glutamine.
Cell exposure
Prior to in vitro exposure, a stock suspension was made in glass tubes containing 1 mg/ml nanomaterials in
their respective cell culture media, supplemented with 10% FBS. The stock was sonicated for 20 minutes and
diluted to final concentrations of 300, 30 and 3 µg/ml. Cell monolayers at about 70% confluence were exposed
for 24h (37oC, 5% CO2) with 35 µl (96 wells plate) 400 µl (12 wells plate) or 1 ml (6 wells plate) of the
desired nanomaterial, corresponding to doses of 31.5, 3.15 and 0.315 µg/cm2. This dose range was chosen
such that cells retain > 70% viability after exposures. Unexposed cells in adjacent wells were taken along as
controls. After exposures, cells were washed three times with warm DPBS and harvested by trypsinization
(A549, MRC9) or scraping (Macrophages).
Sample preparation for LC-MS/MS
Cell cytoplasm was enriched by ProteoJET™ Cytoplasmic and Nuclear Protein Extraction Kit (Fermentas,
Waltham, MA, USA). Excess nanotubes were washed off from cell monolayers 24h after exposures. Cells
were harvested and pelleted with cold PBS. Cell lysis buffer supplemented with 1X protease inhibitor cocktail
(Halt™ Protease and Phosphatase Inhibitor Cocktail, EDTA-free, Thermo Fisher Scientific, Waltham, MA,
USA) was then added to cell pellets and cytoplasmic protein extracts were isolated as per kit instructions.
Protein concentrations were measured with a BioRad DC protein assay kit. Tryptic peptides for label free
proteomics were prepared according to standard procedures.
LC-MS/MS proteomic analysis, data acquisition and label free quantitation
Each peptide mixture was analyzed by automated nanoflow capillary LC–MS/MS using a nanoLC 1000
(Proxeon, Thermo Fisher Scientific) coupled to a benchtop quadrupole orbitrap mass spectrometer
(QExactiveTM, Thermo Fisher Scientific). Proteome quantitation was performed using a bottom up data
dependent acquisition approach on a QExactive platform. Column specifications, reverse phase peptide
separation on 3h gradients and MS/MS data acquisition parameters have been described (Cypryk et al. 2016).
In total three independent exposures of either swCNT, mwCNT or unexposed (Control) were carried out for
each cell type, followed by three LC-MS/MS injections per exposure, generating a total of 81 raw files. Label
free quantitation (LFQ) was performed with the MaxQuant software (Cox et al. 2014) followed by differential
abundance analysis with Perseus – a computational platform that is incorporated into the MaxQuant shotgun
proteomics pipeline (Tyanova et al. 2016). Maxquant output files containing all identified and quantified
protein groups for each cell type are provided as additional files 1, 2 and 3. For analysis of differential
abundance between treatment groups, 1-way ANOVA or student t test, were employed when appropriate,
followed by benjamini-hochberg false discovery rate adjustment of 5%.
Pathway analyses
General pathway analysis, molecular function enrichment, annotated disease functions and canonical toxicity
function enrichment was carried out in IPA (Ingenuity®, Qiagen, Hilden, Germany).  Biological pathway
comparison analysis was carried out for all DA proteins using the Funrich functional enrichment analysis
software tool (Pathan et al. 2015).
Western blot validation of label free proteomics
Whole cell lysates from pelleted exposed cells were obtained by urea lysis (8M urea/100mM NaCl/10mM
TrisHCl, pH8.0). Samples were normalized to same total protein concentrations with urea lysis and SDS
buffers after the protein concentration of each sample was determined using the PierceTM BCA protein assay
kit (Thermo Fisher Scientific). 15 µg of sample per well were loaded in 12 wells pre-cast CriterionTM gels.
Anti RBP4 (ab133559 - abcam) and anti SCDBP (ab155394 – abcam) antibodies were used to probe gel blots
at dilutions of 1:2000(v/v) in 4% milk, overnight at 4 0C, followed by 30 min wash with 1xTBS + 0.1% Tween,
and 1h incubation with1:2000 diluted secondary antibodies respectively. For ECL-based detection, blots were
probed for 1h at room temperature with HRP-labelled anti-rabbit and anti-goat antibodies at dilutions of
1:2000 (v/v) in 4% milk. Protein band intensities were quantified with Imagej (Abràmoff et al. 2004) and
expressed as log2 transformed mean ±SEM.
Adverse outcome assays
Equal cell densities were seeded into parallel 96 well plates prior to nanomaterial exposures, to have a
sufficient number of wells for triplicate analyses of three independent adverse exposure outcomes. Dose-
dependent changes in cell viability, reactive oxygen species (ROS) production and decrease in mitochondrial
membrane potential were all measured 24h post exposure using commercially available 96 well format assays.
Cell viability was determined using a CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Mitochondrial membrane potential was measured according to procedures described in the Mito IDTM
membrane potential kit (Enzo Life Sciences). Cellular ROS production was determined using a fluorescence-
based 2’,7’ –dichlorofluorescin diacetate (DCFDA) assay (abcam, Cambridge, UK). All assay procedures
were carried out as described in assay protocol, and the only slight modification was the maximum excitation
and emission spectra (490 nm and 535 nm respectively) used to measure fluoregenic dichlorofluorescin. For
acellular ROS production, 20 µg/ml nanomaterial suspensions were prepared in PBS. 0.03 mM DCFDA was
deacetylated for 30 min at room temperature by addition of 0.01M NaOH. Deacetylated DCFDA was then
added to 50 µl of nanomaterials in 96 well viewplatesTM at a final concentration of 0.015 mM. After incubation
for 3h at 370, nanomaterial-depleted supernatant was obtained by centrifugation at 4000 rpm for 10 mins. 50
µl supernatants were transferred to fresh plates containing 100 µl PBS and dichlorofluorescin formation was
measured as described above.
Availability of data and materials
The MaxQuant analysis pipeline output (identified and quantified protein groups) for each cell type (.txt
files), and mass spectrometry raw files are available from the corresponding author on reasonable request.
RESULTS
Physicochemical characteristics of CNTs
The two CNT subtypes evaluated in this study have been previously extensively characterized (chemical
composition, size distribution and surface charge) in similar dispersion and exposure media. Herein, we re-
characterized the size distribution and surface charge in cell culture media supplemented with 10% FBS.
MwCNTs had a size of 432 nm and swCNTs were found to be in the size range of 259 (33.5%) to 1393 (57%)
nm. The surface charge for both CNT subtypes were similar (±0.3 mV). CNT primary size, size in dispersion,
chemical composition and surface charge are outlined in Supplementary Table S1.
Effect of CNTs on cell viability
A dose-dependent decrease in cell viability was measured for all 3 cell types after 24 hours of exposure to
CNTs. Exposure to similar mass concentrations of asbestos crocidolite were carried out in parallel to serve as
cytotoxicity control. More than 70% viability was observed for all cell types at nanomaterial concentrations
of up to 31.5 µg/cm2 (Figure S1).
Evaluation of spatial and temporal proteome modulation
Proteomic characterization of enriched cytoplasmic fractions was carried out in cells exposed to 31.5 µg/cm2
CNT. A total of 5353 unique protein groups were identified in all 3 cell types corresponding to 4252 protein
groups in the A549 cell line, 2850 in the MRC9 cell line and 3864 in monocyte-derived macrophages. Based
on Ingenuity®’s knowledgebase, 57% of all identified proteins were classified to originate from the cytoplasm.
Of the remaining proteins, 5% were assigned to the extracellular space, 19% to the nucleus, 12% to the plasma
membrane and 7% to other cellular compartments. Multiple sample testing at a maximum FDR of 5%, reveals
the abundance of 275, 561 and 552 proteins in A549, MRC9 and macrophages, respectively, were altered by
exposure to both CNTs. Principal component analysis and K-means clustering grouped all biological
replicates according to the different cell and exposure types (Figure 1A and 1B). Fold change in protein
abundances between exposed and unexposed cells were derived using a student’s t-test (S0 of 0.5 and FDR of
0.05). Significant differentially abundant proteins identified in the mwCNT/Control and swCNT/Control, had
a change in abundance ranging from 1.5- to 20-fold (Table S2). A Venn diagram distribution of these
differentially abundant (DA) proteins is depicted in Figure 1C. Only 2 (APOC3, PTMS) and 3 (APOC3,
NME1, IGF2) proteins are DA across all cell types in the mwCNT/Control and swCNT/Control contrasts
respectively (Figure 1C). Highly upregulated proteins (> 6-fold) in response to mwCNT or swCNT exposure,
for each cell type, are summarized in Table 2. Taken together, the extent of fold change in protein abundance
and/or the number of differentially abundant proteins was greatest in swCNT-exposed cells (Figure 2). About
67% of all DA proteins were unique to swCNT-exposed cells and 19% to mwCNT-exposed cells.
Notwithstanding, although only 14% of all DA proteins were found to be common between the mwCNT and
swCNT exposures, this corresponds to 43% of the DA proteins in mwCNTs exposures, and is an indication
that the adverse response to these two CNT subtypes is mediated by overlapping mechanisms.
Oxido-reductive activity, structural constituent of ribosome, and RNA binding are the main molecular
dysfunctions linked to bio-CNT interactions.
In the mwCNT/Control contrast, DA proteins mapped to 50 (A549), 20 (Macrophages) and 223 (MRC9) genes
and in the swCNT/Control contrast to 112 (A549), 442 (Macrophages) and 196 (MRC9) genes. Bearing in
mind the apparent cell-type specificity of the molecular responses to these two CNT subtypes (Figure 1C), a
comparative analysis of functionally enriched pathways was carried out on merged DA proteins from all three
cell types. This approach averages out those responses that are due to specialized cell type functions, leading
to a more generalizable snapshot of the cellular functions that are affected by adverse of bio-CNT interactions.
DA proteins from the exposure/control contrasts in all 3 cell types mapped to a total of 942 non-redundant
genes, corresponding to 273 genes in mwCNT/Control and 669 genes in swCNT/Control, of which 116 genes
were common between both sets (Figure 2A).
The most enriched molecular activities together with the affected pathways are summarized in Figure 3. Key
molecular activities represented by DA proteins were similar for both mwCNT and swCNT exposures, and
these corresponded to ribosome structural constituents, oxidoreductase activity and RNA binding (Figure 3A).
These enriched molecular functions were most associated with pathways corresponding to protein synthesis
and cell morphology in mwCNT exposures, with free radical scavenging and cellular assembly/organization
in swCNT exposures and with cell death/survival and post-transcriptional modifications in both exposures
(Figure 3B). Based on the direction of fold change in protein abundance, the top-most predicted disease
endpoints were associated with increased cell proliferation and decreased DNA repair ability. Inflammation
(LXR/RXR and FXR/RXR), cell proliferation and fibrosis, were most significantly enriched as top disease
and toxicological functions in DA proteins from the swCNT exposures (Figure 3). Mitochondrial dysfunction
was the most enriched toxicity related outcome for both of these CNTs. The p-value for enrichment of DA
proteins corresponding to mitochondrial dysfunction was most significant in the swCNT exposures. To shed
more light on the distinctive bioactivities between these CNT subtypes we performed a comparison analysis
of the top common biological pathways represented by all DA proteins and then separately for downregulated
and upregulated proteins (Figure 4). For these comparison analyses, two criteria were employed; the
percentage of DA proteins from the input dataset (mwCNT/Control or swCNT/Control) that mapped to a
specific pathway was used to infer the relative importance of that pathway amongst all the pathways triggered
by the same input genes and the number of DA proteins was used to infer the relative potency with which a
specific pathway was affected by each of the two CNT subtypes. The top shared pathways that were
differentially represented by all DA proteins from the mwCNT and swCNT exposures were; diabetes
pathways, translational regulation, mRNA processing pathways and respiratory electron transport. Amongst
these four, the most similar pathway between the two exposures was the respiratory electron transport system
of the mitochondria, which was affected by about 15% of DA proteins from both exposures. However, this
corresponded to around 40 DA proteins in the mwCNT exposures and 106 DA proteins in the swCNT
exposures (Figure 4A). The greatest differential representation among the top pathways was observed for
ribosome-associated pathways (translation elongation, formation of free 40s subunits, etc.) and spliceosome-
associated pathways (mRNA splicing, mRNA transcript formation and maturation, pre-mRNA processing).
The ribosome was predominantly modulated by mwCNTs (31% mwCNT vs. 3% swCNT), and the
spliceosome by swCNTs (11% swCNT vs. 3% mwCNT) – Figure 4A. Further stratification of all DA proteins
into downregulated and upregulated proteins for each exposure type reveal that the bulk of proteins
representing the spliceosome were downregulated following CNT exposure (Figure 4B), while the reverse
held true for biological pathways relating to ribosomal function (Figure 4C). Interestingly, although the ratio
of DA proteins corresponding to the respiratory electron transport system was comparable for both exposures,
none of the DA proteins from this pathway were downregulated in mwCNT/Control, as opposed to the
swCNT/Control exposure wherein biological pathways indicative of mitochondrial dysfunction were biased
towards downregulated proteins (Figures 4B-C and Figure S2). Other notable differentially activated pathways
were; downregulation of proteins involved in induction of cell death (NF-kB, FAS and Caspase signaling),
upregulation of lipid metabolism and integrin cell surface interactions.
Immunoblot validation of quantitative proteomics
To highlight the reliability of label-free proteomics quantitation, two in-house antibodies against RBP4
(retinol binding protein 4) and SDCBP (syntenin-1), were used to re-assess protein abundance levels via
western blot following new rounds of exposure to 3 different doses of mwCNT and swCNT. Figure 5 depicts
a side-by-side view of LC-MS/MS quantitation (0 and 31.5 µg/cm2) and western blot validation (0, 0.315,
3.15 and 31.5 µg/cm2). For both proteins, the direction of change in abundance following CNT exposure was
similar for LC-MS/MS and western blot quantitation. Representative protein blots are also shown.
In vitro analysis of distinctive oxidoreductive potencies
Based on the aforementioned comparison criteria (Figure 4), we deduced that respiratory electron transport
dysfunction was the most significant pathway common to adverse exposure of both CNT subtypes, with the
single-walled variant appearing to be more potent. To validate this, we investigated ROS production capacities
of both materials in vitro and in vivo, as well as their abilities to decrease mitochondrial membrane potential.
Intracellular reactive oxygen species (ROS) was measured 24h post exposure to mwCNT and swCNT with
asbestos crocidolite exposures as positive control. ROS production was dose-dependent in all 3 cell types
(Figure 6). At all tested doses (0.315, 3.15 and 31.5 µg/cm2) CNT-induced ROS production was greater than
that in cells exposed to similar mass concentrations of asbestos (Figure 6A-C). Intracellular ROS production
was similar for both CNT subtypes at 0.315 µg/cm2, but 2- to 3-fold higher in cells exposed to 3.15 and 31.5
µg/cm2 swCNTs. At a CNT dose of 31.5µg/cm2, induction of intracellular ROS production over 24h was
decreased by treatment of A549 cells with routinely used antioxidants; N-acetylcysteine, Pyrrolidene
dithiocarbamate and Diphenyleneiodonium (Figure 6D). At the concentrations tested, these antioxidants were
more effective at inhibiting ROS production in the mwCNT exposures and N-acetylcysteine was the most
effective antioxidant. Only N-acetylcysteine significantly inhibited ROS production in the swCNT exposure.
To answer whether material chemistry or unknown contaminants could explain these differences in
intracellular ROS production, cell-free ROS generation at nanomaterial concentrations of 20 µg/ml was
examined for each material. Carbon black – a nano-sized particle composed entirely of carbon was included
as a chemical composition analogue of CNTs. Cell-free ROS production was comparable for both mwCNTs
and swCNTs and only around 1.5 times less than that produced from carbon black. Surprisingly, acellular
ROS production by asbestos crocidolite was about 10 times less when compared to these CNTs (Figure 6E).
24h after exposure to each material, a decrease in mitochondrial membrane potential (↓MMP) was observed
at all tested doses. ↓MMP was most prominent in Macrophages and MRC9. SwCNTs were found to be the
most potent inducers of ↓MMP. A dose-dependent ↓MMP in all 3 cell types was only observed for the swCNT
exposures (Figure 7).
DISCUSSION
Although in vitro assays remain highly relevant as initial screens to predict ENM risk and prioritize the degree
of testing for in vivo studies,(Godwin et al. 2015) it is not straightforward to derive organism-level health
impact assessment from in vitro models. We exposed multiple cell types with relevance to inhaled CNTs, and,
by combining their unique proteomic responses, we obtained a more generalizable view of the systemic effects
of adverse CNT exposure, than if investigating only one cell type. At 1 – 5 µm in length, these nanotubes fit
the current description of “short” nanotubes, defined to be less than 10 – 15 µm in length.(Bernstein 2007) In
concordance with earlier studies, these short(er) CNTs are mildly cytotoxic, requiring very high concentrations
to decrease cell viability by more than 50% (Palomäki et al. 2010; Catalán et al. 2012). A greater than 50%
reduction in cell viability was seen only in macrophages exposed to 315 µg/cm2 swCNTs (Figure S1). A 10-
fold lower dose (31.5 µg/cm2), at which greater than 70% viable was retained in all exposures was used to
elucidate systemic differences in adverse CNT response pathways between mwCNTs and swCNTs. For
consistency, the same dispersion protocols with previously published studies comparing the same materials
were used (Sund et al. 2011; Catalán et al. 2012). We analyzed the cytoplasm for two main reasons; firstly,
subcellular proteome characterization has the appeal of its decreased sample complexity which results in
improved depth of characterization as opposed to the entire cellular proteome. Secondly, once within a cellular
environment, CNTs are exposed to the cytoplasm and encompassing macromolecular complexes, wherein
protein synthesis, modification and trafficking take place. Whilst global protein abundance profiles might
reflect a pathophysiological state, they are incomprehensive from a mechanistic point of view as other facets
of protein regulation like changes in spatial distribution are largely missed. To take advantage of this we used
a gentle cytoplasmic fraction enrichment method, which leaves other cellular organelles intact.
Previous studies have reported that CNTs have an extremely high affinity for cell lysate cytoskeletal proteins
(Sund et al. 2011; Cai et al. 2013). Because cytoskeletal proteins are highly relevant for intracellular and
vesicular trafficking (Rogers & Gelfand 2000; McGinnis et al. 2002; Caviston & Holzbaur 2006), this supports
our findings that specialized macromolecular complexes that require multiprotein assembly and targeting, like
the ribosome and spliceosome, were affected by CNT exposure. Competitive binding of cytoskeletal proteins
to CNTs could be one of the ways that they affect the spatial distribution and function of these multiprotein
complexes. There have thus far, been no reports about CNTs inducing ribosome and spliceosome dysfunction.
Nonetheless, several studies have contradicted the long-standing notion that ribosomal proteins serve
‘housekeeping’ functions, as they have been found to be deregulated in several cancers (Naora & Naora 1999;
Kreunin et al. 2007; Khimani et al. 2005; Xue & Barna 2012; Sulima et al. 2014). Alternative mRNA splicing,
mediated by a complex of highly conserved proteins, termed the spliceosome, is a recognized gene regulatory
mechanism with important implications for tumor onset and progression, (van Alphen et al. 2009) as well as
in controlling the magnitude and duration of innate immune responses (Carpenter et al. 2014). The
spliceosome was also identified as an enriched pathway in a toxicogenomics study investigating  cytotoxicity
induced by DNA damage in zebrafish cell lines (Li et al. 2016). Depending on their physicochemical attributes
and degree of dispersion, CNTs can penetrate cells via diffusion, endocytosis or phagocytosis (Raffa et al.
2009). Both CNT subtypes are short but differ in size, surface area, diameter/length ratios, protein binding
affinities and hence most likely, cellular uptake efficiencies (Table S1). It is plausible that in addition to its
higher aspect ratio, the smaller swCNT fractions (33% with a size of 259nm) could have been more efficiently
taken up by cells, conferring a greater potential to cause physical injury. Preferential modulation of the
ribosome and spliceosome by mwCNTs and swCNTs respectively, could represent an extension of the
differential potency between these CNT subtypes, wherein, deregulated splicing occurs downstream of altered
ribosomal functioning. However, a dose-response proteomic assessment will be required to confirm this.
Increased intracellular production of reactive oxygen species (ROS) that can be counteracted by pretreatment
with antioxidants has established oxidative stress as a hallmark of CNT-induced toxicity (Shvedova et al.
2012). We identified oxidative stress as a central common mechanism, governing adverse exposure to
mwCNTs and swCNTs (Figure 4A). Structurally intact mitochondria have a well-known role in balancing
general oxidative status via their involvement in ROS metabolism. As such a net increase in ROS triggers a
cycle whereby accumulating ROS further damages mitochondria causing more free radical production, and
loss of the cells antioxidant capacity (Andreyev et al. 2005). Pathway analysis highlight that the outcome of
CNT-induced ROS production was tightly linked to mitochondrial dysfunction and radical production by the
mitochondrial respiratory electron transport chain, involving complex I – IV in mwCNT-exposed cells and
complex I – V in swCNT-exposed cells (Figure S2). The greater potency of intracellular ROS induction by
swCNTs is in line with observations that antioxidant treatment was more adept at decreasing ROS production
in mwCNT-exposed cells than cells exposed to swCNTs (Figure 6D), and on a systemic level, proteins
representative of mitochondrial dysfunction were most enriched in swCNT-exposed cells (Figures 3 and 4).
Consistently EGFR1, TNF alpha and NF-kB signaling, often associated with altered ROS homeostasis,
inflammasome signaling and fibrosis, within the context of adverse CNT exposures (Vietti et al. 2016) were
also enriched by DA proteins.
Particle chemical composition indicate that both CNTs primarily consist of C (> 99%). This chemical
composition similarity, is mirrored by their intrinsic oxidative potential (Figure 6E), which is more
comparable to cell-free ROS levels generated by carbon black (100% C content) as opposed to that produced
by asbestos crocidolite [NaFe32+Fe2 3+Si8O22(OH)2]. Iron ions localized to the surface of asbestos are
responsible for cell-free ROS production (Liu et al. 2013) however there isn’t any consensus in the scientific
literature with regards to abiotic ROS production by CNTs and it remains unclear if and how nano forms of
carbon generate cell-free ROS. Regardless, nanoparticles have been observed to exhibit distinctly different
properties from their bulk counterparts (Oberdörster et al. 2007). In agreement with our cell-free ROS data,
metal ion independent radical production has also been observed for multi-walled CNTs and carbon black
(Muller et al. 2008; Nymark et al. 2014). Absence of intrinsic ROS-producing capacity by CNTs has been
documented in several studies (Shvedova et al. 2012) meaning that our cell-free ROS data must be interpreted
with caution.
As there is no nanomaterial “exposure disease” per se, current surveillance and epidemiological studies are in
most cases not specific to individual types of ENMs. Hazard markers are thus required for assessment of
adverse exposure to specific materials. Only 1 protein was affected by both CNT subtypes in all 3 cell types
– APOC3 (Apolipoprotein C-III). APOC3 was consistently upregulated (5- to 15-fold) in response to both
mwCNT and swCNT in all 3 cell types. APOC3 and associated lipoproteins have been identified as key
components of the protein corona of silica nanoparticles (Tenzer et al. 2013; Ritz et al. 2015). In this dataset,
in addition to APOC3, the apolipoproteins; APOA2, APOB, APOC2, APOD and APOH were upregulated in
response to CNT exposure (Table 1 and Table S2). Elevated APOC3 is associated with hyperlipidemia and an
increased risk of developing cardiovascular disease (Norata et al. 2015).Since upregulated APOC3 levels are
also associated with metabolic syndrome and type 2 diabetes mellitus, it is worthy to mention that APOC3
was most abundantly upregulated (14-fold) in macrophages exposed to swCNT, and incidentally, the most
upregulated protein in this study was INS – upregulated more than 20-fold in macrophages exposed to swCNT.
Hypersecretion of insulin occurs in response to insulin resistance (metabolic syndrome) as well in response to
ER stress (reviewed in Salvadó et al. 2016).  In total, 92 and 23 proteins involved in insulin synthesis and
processing were DA in the mwCNT/Control and swCNT/Control exposures respectively (Figure 4A). One of
these proteins - retinol binding protein 4 (RBP4), is amongst the proteins that we have validated by western
blotting in this study. NME1 and SMAP1 are the only proteins that are differentially regulated in response to
swCNT in all 3 cell lines. NME1 – Nucleoside Diphosphate Kinase 1, was found to be 3- to 11-fold
downregulated in response to swCNT exposure. NME1 is responsible for synthesis of nucleoside
triphosphates other than ATP, and is a well-described metastasis suppressor gene (McCorkle et al. 2014).
SMAP1 – stromal membrane associated protein 1, is a GTPase activating protein whose overexpression has
been shown to regulate clathrin-dependent endocytosis in Hela cells (Tanabe et al. 2005). SMAP1 is about 3-
fold downregulated in A549 and MRC9 cells but then 8-fold upregulated in primary macrophages. PTMS
(parathymosin) was the only protein that was upregulated (3- to 9-fold) uniquely in response to mwCNT
exposure in all three cell types. In a study examining the global effects of toxic metals on gene expression,
PTMS transcripts were found to be 2-fold upregulated (Andrew et al. 2008). Another protein worth mentioning
is HIG1 hypoxia inducible domain family, member 1A (HIGD1A). HIGD1A, required for morphological and
functional integrity of the mitochondria (Hayashi et al. 2012; An et al. 2013), was 4-fold downregulated in
response to mwCNT exposure in A549 cells and 5-fold upregulated in response to swCNT in primary
macrophages and MRC9 cells.
CONCLUSION
In the current study, evaluation of adverse exposure events at the cellular and molecular level shed more light
on the health hazard of carbon nanotubes. We identified systemic similarities and differences in the
pathotoxicological responses of two well-characterized CNT subtypes. In addition, some of the highly
upregulated proteins could be developed into exposure-specific hazard markers. Recognized toxicants like
asbestos crocidolite (Panduri et al. 2003; Huang et al. 2012; Nymark et al. 2015) and long needle-like
mwCNTs (Wang et al. 2012; Nymark et al. 2015) have been shown to cause mitochondrial dysfunction by
inducing a decrease in mitochondrial membrane potential (↓MMP). It is interesting to observe that these
shorter CNTs that we found to be mildly cytotoxic, decreased the MMP to levels that were comparable with
asbestos crocidolite. Although high aspect ratio seems to be the closest correlate to CNT-induced cytotoxicity,
their biodurability demands that the hazard potential of low aspect ratio CNTs should not be ignored. Here-in
we show how CNT-induced ROS production is closely associated with mitochondrial dysfunction, and the
molecular components thereof. As a second highlight of this study, we propose two additional paradigms
(ribosome and spliceosome functionality) through which adverse exposure to CNTs can be additionally
explored. Just like the mitochondrion, the ribosome and spliceosome are central macromolecular complexes
with high relevance for overall cellular homeostasis and proliferation state. Taken together, our data reveal
that short rod-like CNTs still represent a health hazard, and for rod-like CNTs of similar length, the single-
walled variant may represent a higher toxicity propensity, the potential of which could be manipulated by
increasing the number of graphene layers. From a technical point of view, we have also shown that analysis
of cytoplasmic proteome abundance provides sufficient mechanistic insight to distinguish similar CNT
subtypes with the added benefit of being easier to characterize than whole cell lysates.
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FIGURES
Figure 1: Comparative profile of differentially abundant proteins across the different cell types and
exposures using a cluster dendogram (A), principal component analysis (B, upper panel) and heat map (B,
lower panel). In (A) C represents the controls or unexposed cells, while mwCNT and swCNT represent cells
exposed to multi-walled and single-walled CNTs respectively. Hierarchical clustering of all differentially
abundant proteins distinguishes different cell and exposure types (A). For each cell type, a principal
component and heatmap analyses of the top-most differentially abundant proteins (1% FDR) reveals that in
A549 and Macrophages, mwCNT-exposed cells have a greater proteome profile similarity with unexposed
cells, while in MRC9 cells mwCNT exposure was more comparable with the swCNT exposure. In the heatmap
mean protein abundance is represented as green (low) to red (high). Venn distribution of differentially
abundant proteins (fold change ≥2) from mwCNT/Control and swCNT/Control contrasts across all 3 cell types
are depicted in panel (C).
Figure 2: Number of differentially abundant proteins and degree of change in protein abundance. In
total, the differentially abundant proteins from the mwCNT/Control contrast mapped to 273 genes and those
in the swCNT/Control contrast to 669 genes. 116 genes were common between the two contrast sets (upper
panel). In the lower panel, a plot of the number of DA proteins and the total fold change of DA proteins for
each exposure type across all 3 cell types reveal a greater proteome perturbation in swCNT-exposed cells.
*represents the sum of fold change in protein abundance, irrespective of direction of fold change.
Figure 3: Pathway analysis summary of differentially abundant proteins from all 3 cell types.
Figure 4: Comparative analysis of top overlapping biological pathways. Differential enrichment analysis
of shared biological pathways between mwCNT- and -swCNT exposed cells was performed at 3 levels; using
combined differentially abundant (DA) proteins from the exposure/control contrasts in all 3 cell types – i.e.
279 DA proteins in mwCNT/Control and 669 DA proteins in swCNT/Control (A), using only those DA
proteins that were downregulated (B) and upregulated (C) between the two contrast sets in all 3 cell types.
For these analyses, the importance of a mechanism was attributed to the percentage of DA proteins from a
specific pathway, within the input dataset (*heatmap on the left), while the potency of that mechanism was
attributed to the total number of DA proteins representing the pathway for each contrast (**heatmap on the
right). MwCNT, swCNT and C, represent mwCNT-exposed, swCNT-exposed and unexposed cells
respectively. The percentage of DA proteins allocated to pathways suggestive of oxidative stress were
similarly represented (about 15%) in mwCNT/C and swCNT/C, suggesting that it is an equally important
mechanism of toxicity for both CNT subtypes, however, the number of DA proteins indicate that swCNTs are
more potent in this regard (A). In the same way, pathways suggestive of ribosomal dysfunction (translation
elongation, mRNA translation, peptide chain elongation, insulin synthesis and processing) were revealed as
being principal mechanisms of mwCNT-induced toxicity as opposed to mechanisms of spliceosome function
(mRNA splicing, processing, maturation). The later were most activated by exposure to swCNTs (A).
Stratification into clusters of downregulated or upregulated DA proteins reveal that the mechanisms of toxicity
triggered by mwCNT exposure are mostly mediated by upregulated proteins as opposed to swCNT-induced
mechanisms of toxicity (B and C). Other common mechanisms between the two exposures were
downregulation of proteins involved in caspase cascade in apoptosis (B), upregulation of proteins involved in
lipid metabolism (C), both of which are more enriched in swCNT exposures.

Figure 5: LC-MS/MS quantitation versus western blot analysis. Western blot analysis was performed
following triplicate 24h exposure to 0.315, 3.15 and 31.5 µg/cm2 mwCNT and swCNT. Antibodies to RBP4
(retinol binding protein 4) and SDCBP (syntenin-1) were used to validate LC-MS/MS quantification. C
denotes unexposed control cell and mwCNT/swCNT denote cells exposed to multi-walled/single-walled
carbon nanotubes. 15 µg of whole cell lysate were loaded for all samples, and each sample was loaded twice,
in adjacent lanes. The leftmost panel in the figure depicts log2-transformed protein abundance intensity,
derived from LC-MS/MS proteomics. The rightmost panel depicts a representative blot of its expression levels
as determined by western blot and the middle panel shows log2-transformed intensity-based quantitation
(mean ±SEM) of western blot data. For intensity-based representation of undetected bands, an area of the blot
with no detectable protein bands was selected.
Figure 6: Nanotube-induced ROS production. Intracellular ROS was determined in all cell types 24 hours
after exposure to mwCNT, swCNT and Asbestos Crocidolite (A, B, C). All 3 nanomaterials induced a dose-
dependent increase in reactive oxygen species with swCNT being the most potent. Even at mass concentrations
that were 10-fold higher, ROS production in cells exposed to asbestos crocidolite (315 µg/cm2) was still
significantly lower than that in cells exposed to both CNT subtypes (31.5 µg/cm2). Cells were treated with
acknowledged antioxidants – N-acetylcysteine (NAC), Pyrrolidene dithiocarbamatec (PDTC) and
Diphenyleneiodonium (DPI), 1h before and during the 24h exposures (D). All 3 antioxidants significantly
decreased (P < 0.005) ROS produced by exposure to mwCNT, but only NAC was able to decrease ROS
induction in swCNT exposures. Acellular production of ROS was determined after 5h incubation in NaOH-
deacetylated DFCH-DA, at nanomaterial concentrations of 20 µg/ml (E). ROS generation is quantified as the
fluorescence intensity of DCF oxidized from non-fluorescent DCFH, at excitation emission/spectra of
485nm/535nm. Error bars are standard error of the mean from 4 replicates. NMs without DCFH represents
the mean ROS measured from either mwCNT, swCNT or asbestos crocidolite in the absence of DCFH.
Figure 7: Decrease in mitochondrial membrane potential (MMP) 24h post exposure to multi-walled CNTs
(mwCNT), single-walled CNTs (swCNT) and asbestos crocidolite across three cell types. Fluorescence
intensities for each exposure was subtracted from that in unexposed cells. Columns represent mean and SEM
of fluorescence intensity from at least 3 replicates. As positive control cells were exposed for 1h to 100µM
Carbonyl Cyanide 3-ChloroPhenylhydrazone. Exposure to all three all materials, resulted in a significant
decrease (P value < 0.05) in MMP at all the tested doses, meanwhile this decrease was dose dependent in at
least 1 cell type in only swCNT and Asbestos exposed cells (P value < 0.005). In the mwCNT-exposed cells,
MM depolarization observed at the lowest dose wasn’t exacerbated by higher doses of mwCNTs.
Table 1: Highly (> 6-fold) upregulated proteins
A549 Contrast Gene symbol Fold change
mwCNT/Control RPL36A
KIAA1107
SVIL
NUDT4
MRPS33
CHMP2B
APOC3
KIF3C
9.1
7.5
7.3
7.3
6.7
6.6
6.1
6.1
swCNT/Control FAXC
RBP4
SVIL
IGF2
OSTC
SMAD2
TCEAL1
10.3
7.8
7.7
7.7
7.3
6.7
6.1
Macrophages mwCNT/Control APOC3
PTMS
DPM3
APOA2
CD99
SMAP1
APOD
INS
11.8
10.0
8.8
8.8
7.6
7.3
6.5
6.1
swCNT/Control INS
SERPINB6
APOC3
AHSG
AFM
HP;HPR
POTEJ
SMAP1
PGLYRP2
SLAMF7
SPN
PICALM
APOD
APOH
SERPINB8
ORM2
A1BG
APOA2
ORM1
ENTPD8
CEP164
HBB
SDCBP
NOTCH2
SLC9A1
CD47
CD74
GAL
AMBP
SERPINB9
20.4
15.3
14.1
13.1
11.4
10.0
9.8
9.3
9.2
9.2
9.2
8.8
8.8
8.4
8.3
7.9
7.9
7.7
7.6
7.5
7.3
7.0
6.4
6.3
6.3
6.2
6.2
6.2
6.1
6.1
MRC9 mwCNT/Control NPC1
APOC3
TSNARE1
HBA2
9.4
7.3
7.2
7.1
swCNT/Control ITGA2
RBP4
APOC3
TSNARE1
ITM2B
CCDC80
LYRM4
10.2
8.0
7.5
7.1
7.1
6.6
6.3
ADDITIONAL FILES
Figure S1: Cell viability (Cell Titre-GloTM luminescence assay). Cell monolayers; A549 (A), Macrophages
(B) and MRC9 (C) were exposed for 24h to mwCNT, swCNT and Asbestos Crocidolite nanofibers. Percentage
viability is derived from the ratio of the luminescence signal at each concentration to the average of that
measured in unexposed (0 µg/cm2) cells. Error bars are standard error of the mean from 3 technical replicates.
Figure S2: Ingenuity®-derived depiction of gene mutations associated with mitochondrial dysfunction.
Downregulated proteins from our proteomics dataset are highlighted in green whilst upregulated proteins are
colored red.
Table S1: Primary and dispersion characterized carbon nanotube physicochemical properties
aProvided
by
vendor
(SES
Research)
bCalculated as minimum length divided by maximum diameter
1.  Sund J, Alenius H, Vippola M, Savolainen K, Puustinen A. Proteomic characterization of engineered
nanomaterial-protein interactions in relation to surface reactivity. ACS Nano. 2011;5(6):4300–9.
2.  Vippola M, Falck GCM, Lindberg HK, Suhonen S, Vanhala E, Norppa H, et al. Preparation of nanoparticle
dispersions for in-vitro toxicity testing. Hum Exp Toxicol. 2009 Jun;28(6–7):377—385.
Material Catalogue
number
Compositio
n(%wt.)(1)
aPrimary size Surface
area(2)
Size in
dispersion
Zeta
potential in
dispersion
Short
purified
MWNT
(mwCN
T) SES
Research
900-1260 Ø 95%
nanotub
es
Ø 95%
MWNT
Ø < 2%
amorpho
us C
Ø < 0.2%
ash
content
Ø Length: 1
– 2 µm
Ø Outer
diameter:
10 – 30
nm
Ø bMinimum
length-to-
diameter
ratio: 33/1
436
m2/g
96.3%: 432
nm
3.7%: 4.4
µm
-13.35 mV
Short
purified
SWNT
(swCNT)
SES
Research
900-1351 Ø 90%
nanotub
es
Ø 50%
SWNT
Ø < 5%
amorpho
us C
Ø < 2%
ash
content
Ø Length: 1
– 5 µm
Ø Outer
diameter:
< 2 nm
Ø bMinimum
length-to-
diameter
ratio:
500/1
60 m2/g 56.9%: 1.4
µm
33.5%: 259
nm
9.6%: 4.6
µm
-13.02 mV
Table S2: List of all significant differentially abundant proteins (Upregulated and Downregulated) for each
cell type
A549_mwCNT
A549_swCNT MRC9_mwCNT MRC9_swCNT Macrophages_mwCNT Macrophages_swCNT
Gene names Gene names Gene names Gene names Gene names Gene names
KIAA1107 FAXC KRTDAP ITGA2 APOC3 INS
RPL36A RBP4 NPC1 TSNARE1 DPM3 APOC3
SVIL OSTC TSNARE1 RBP4 APOA2 SERPINB6
THAP5 IGF2 APOC3 KRTDAP CD99 AHSG
APOC3 SVIL HBA2 APOC3 INS PGLYRP2
KIF3C PICALM ASPM ITM2B APOD SLAMF7
CHMP2B DHRS11 PDE4DIP LYRM4 SMAP1 AFM
RPS29 CAST RPS29 PGLYRP2 ORM2
PTMS CLDN2 ASPM AHSG HP
RAB3B APOC3 CD99 BMP1 PPFIBP1 SPN
TCEAL1 DDX19B NDUFC2 IGFBP2 CMC2 POTEJ
RPL29 TSPO RPL34 LOX PRDX4 APOD
GABRA5 SMAD2 NDUFA6 DARS2 H2AFV SERPINB8
AGRN RAB3B CLDN11 ELP2 CPSF2 CEP164
SKA1 MTM1 MRPS7 PSIP1 COL6A5 APOH
NRG1 TCEAL1 GK RNF213 RAB11A SMAP1
SLC52A2 STAMBPL1 DNAJC1 HBA2 HIST1H2BL AMBP
ABI2 DDX17 SDHD ARAP1 H3F3A A1BG
TCIRG1 DHX37 SRC CCDC80 FLAD1 APOA2
COA3 MRPS33 PTMS NDUFS2 HIST1H3A TPM3
SPATS2 SKA1 PSIP1 GTF2A1 DPY19L1
UNC5CL PMM1 BMP1 IGF2 HBB
BOP1 SCRN3 FXR1 SRC PICALM
ZDHHC5 CXorf38 ERLIN1 TGFBI CHMP5
CYSTM1 STAB1 MCU IGFBP4 LRRFIP1
CAMK1D H1FX COX6B1 MRPS21 CASP3
TNFRSF10B PTPLB TMEM179B WDR82 ORM1
TGFBI SRGAP1 COX7C NPC1 NOTCH2
EPS15 OSBPL2 MTX2 IGFBP5 SDCBP
WDR48 RBM26 RBM34 FNDC3B ENTPD8
MSH3 UNK PRKRA NDUFA9 SLC9A1
SGK223 UNC5CL TBL2 MRPS27 CD74
RPL35A HP1BP3 STAU1 TBC1D2 IL8
UBE4A PEG10 SZRD1 CTGF SERPINB9
UNC119 ADD3 FAM115C STAB1 TK2
GEMIN2 CRELD1 MRPS21 DCN SERPING1
SMARCC1 SCD SERINC1 VNN1 CD47
CCDC151 COMMD6 COX6C ATP6AP2 PRDX4
SLC25A4 NDUFB9 NDUFA13 TTR
PM20D2 EPS15 CASP7 TNC HPX
PPP1R8 TGFBI NDUFA9 CHID1 SERPINB1
ISCA1 GNAI1 RRBP1 TBL2 APOC2
HIGD1A MAPK1IP1L PRDX4 ERLIN1 CCL3
CD320 CYP24A1 NDUFS2 PPAP2B ITM2B
LEPREL1 CLNS1A GTF2A1 APOB SPP1
CRADD RFK CLTB RABEP2 KCMF1
FUBP1 H3F3A MRPL37 SRP9 GAL
GEMIN6 NRP2 RECK RPS27L SNCA
BCL2L1 44089 FNDC3B MT-CO2 HBA1
AKAP9 C5orf22 TBC1D2 COX7A2 BSG
CCDC50 MT-CO2 FAM98A C11orf58
LRRC8C TOMM22 DDX17 FAM175B
PAQR5 PPAP2B ATAD3A TRAPPC8
GPX1 CKAP4 ENDOD1 C16orf54
NUDT2 PRRC2C SLC1A4 HN1L
TRIM4 MT-ND4 CST3 SELPLG
DHODH ERLIN2 FN1 WBSCR16
TSEN54 IGF2BP3 MYADM TYROBP
MDP1 TFPI2 CKAP4 ASNS
NIPA1 MRPL28 ABCD3 SERINC1
LYRM7 RPL21 COL5A1 RCSD1
GLRX2 RPS27L RPS14 TFCP2
NBN BROMI RPS21 P4HA2
ALG11 TNC RRBP1 C5AR1
USP3 IMMT VDAC3 GSTM3
NME1 CHCHD3 COL1A2 C20orf27
NUBPL PLAUR RPS20 TMCC3
GOLM1 LBR LMNA NDFIP1
CD320 NDUFV1 IGF2BP1 TNFAIP8
TRAFD1 TRAM1 MTHFD1L ETNK1
GNB1L RPS21 PTTG1IP MTMR14
SMAP1 GNB2L1 HDLBP SQSTM1
FKBP14 COX7A2 RPL23A ARL2
CHMP7 CHID1 NDUFS5 PSMB7
FDX1 SSR4 COX4I1 SARNP
ZFAND1 COX4I1 GNB2L1 TSC22D4
SPTAN1 KRTCAP2 EIF3F ZMIZ2
CTU2 GREM1 IMMT CENPF
METTL3 RPL30 NT5E HEATR5B
CRK RPL13A HADH ISCU
MAPRE3 IKBIP IPO4 ARL6IP5
UBE2L6 ATAD3A RETSAT ARFGAP2
SLC41A3 PTPN9 SNAPIN PLAUR
DHRS3 TECR YWHAG LPL
XYLB NDUFA13 SMAD3 ASMTL
CNIH RPS20 BDH2 EBF2
POLRMT YBX1 SH3BP4 BTRC
GCC1 ATP6AP2 LMF2 GET4
PNMA3 EIF3J C16orf62 RANBP3
SCAMP4 COL4A2 UQCRQ PFKM
MDH1 FAU KIAA1199 HMGA1
GABARAP SSR1 PDCL3 NCS1
STARD9 RPL19 APOL2 MRI1
CCDC151 MT-ND5 RRM2B ARFIP2
ARFIP2 RPL11 RHOB TRAPPC2P1
HIGD2A RPL14 NCDN GPC4
NDUFS3 ACOX1 IL1RN
ARF3 RPL23A DNPH1 SLC38A2
LSM7 DAD1 HGF ALDOC
CHMP1B RPS14 RAB3GAP1 BABAM1
TPM2 TMEM147 TK1 PPFIBP1
TUBAL3 ANXA6 GLIPR1
RPL29 ABCD3 DTYMK MARCKS
AKR1C3 FAM98A SLC4A7 TMEM106B
MYCBP RECQL SNF8 CDV3
SLTM IGF2BP1 DNAJC9 NAF1
RPL28 IKBIP COG3 IFIT5
PFDN1 PIGT SMIM11 DHRS4
PCNP RPL3 SORD PSIP1
DUS3L RPS11 PTPN12 HMGCS1
RPL34 IGF2BP2 GET4 CTSK
ARL15 VDAC3 SDSL MAP1LC3B
RPL37A TMED3 TNKS1BP1
HDLBP EHBP1L1 EPB41L1
RPLP2 ELAC2 HLA-DRB1
UQCR10 LPAR1 FRMD8
TGFBI ACOT13 SDCBP
PTDSS1 RPA2 SLAIN2
RPS8 NOL3 MAP4
NCL NAA25 WASF2
RPL32 LMNB2 NRBP1
MTHFD1L DPP9 CAST
RPL12 TIMM9 PLEK2
RPL22 KIF13B CHMP4B
SND1 FAM162A C9orf142
RPL18 MCCC2 TPD52L2
RPL28 COL4A3BP FBXO7
RPL4 PCBP2 CD276
TMEM258 TAOK3 MCTS1
RPL6 MMS19 PXN
SEC62 RANBP2 ARF5
RPL31 WDR26 PLEKHO2
COX5A DAP CST3
NDUFS1 CCS PPAP2B
EBF2 ATP6V1C1 HOOK3
SGCD HMBS TWSG1
NDUFS8 PTPRK PFDN5
TMED4 SERPINB7 PLA2G7
RPL13 CBR3 EFHD2
HSD17B11 VPS4A CTSD
RPL5 SMAP1 RTN1
RPL15 RNF114 CTSH
RPL18A FADD NECAP2
RPL24 ARF3 PTPMT1
SAMM50 COMMD9 SLC35F6
RPS9 AKR1B10 NPL
EIF3L IAH1 MT-CO2
MGST1 UBE2Q1 NDUFA5
RPS18 ALDH1A1 SQRDL
RPLP0 HDHD1 CYB5R1
LRRC59 CSK COX7A2
RPL17 SCN5A ALDH18A1
KDELR3 MOV10 SLC25A13
FUS LPCAT1 GLG1
NDUFA8 NCAPD2 SLC25A3
RPS3 TUBAL3 COG7
PLAT ARMC9 NDUFB4
RPL7 FUNDC2 NDUFS2
RPL23 COL6A5 DIRC2
YBX3 PSMG3 SLC11A2
MYADM AGPAT1 ST3GAL6
GEMIN5 TBCE SNRPB2
RPS6 SPG20 ABCD3
VDAC2 COASY NNT
RPS3A IPO11 VDAC3
RPL27A RPE NDUFS8
EEF1G RPL36AL LRP1
UFL1 PPP6R3 UQCRC1
RPS4X CLNS1A ZFPL1
RPS24 NAV1 SLC25A24
MGST3 BPHL PHB
EDF1 AKR1C2 PTCD3
UQCRC2 ATP5EP2 NDUFS1
RPS13 HIGD1A NDUFA4
RPSA ATP5G1 SLC25A11
TRIP13 ASAP1 SFXN3
MMS19 PRPSAP2 SLC25A20
IPO4 HSP90AB1 NDUFA10
SH3BP4 HAT1 RPS15
OSTF1 PIP4K2B SLC25A1
CCS COX6B1
UBE2V2 KCMF1 MRPL12
CLNS1A KRT18 TMED2
ENY2 PLAT UQCRC2
HSPBP1 MAP2K1 KHDRBS1
F3 IGBP1 SLC9A6
ATRIP CAP1 ATP5B
IAH1 ASCC2 SCO1
ATP6V1F FAM114A2 DHCR24
TXNDC9 PTMS VDAC1
SLC4A7 SLC39A7 NDUFB10
PTPN12 RPL29 MRC1
SNF8 SPCS1 TIMM17A
SMAP1 S100A6 PET112
TUBB4A NME1 MRPS34
INPPL1 AKR1C3 ILF3
IGBP1 SLC25A6
AKR1B10 MRPL19
ASAP1 PRNP
CROT AGK
RHOB PUF60
WDR26 NDUFA9
PCBP2 MTCH2
HADH SDHC
TUBAL3 DOLK
TBRG4 UQCR10
KRT18 SMDT1
PDCL3 COX5B
ARF3 IMMT
COL6A5 RHOT1
MXRA7 SAMM50
GLRX5 NDUFA13
PIP4K2B CTNNBL1
RAB11A CTSS
PRNP COX7C
ALDH1A1 LACTB
PLP2 MP68
AKR1C3 UQCR11
AKR1C2 MT-ND2
CDC34 IKBKAP
SDHB
HSP90AB1 PCBD2
ASCC2 ATP5J
SNRPD2
ATP5O
GRSF1
TFB2M
TOMM22
MRPL50
GOLGA2
ILF2
MICU1
SRSF11
HIST1H2AC
DDX5
SMIM11
ADD1
GALNT2
NDUFS5
NDUFA3
PQLC1
TBRG4
MRPS18B
MRPS9
MRPS16
APOO
PRPF19
UQCRB
RMDN3
GIMAP1
SF3A1
CRELD1
MRPL3
PXMP4
NUCKS1
TIMMDC1
MRPS35
SLC48A1
NDUFA12
HNRPLL
NDUFB1
MRPS7
ROMO1
RDH14
TMEM199
SNRPD3
MRPL40
SLC35B1
MRPS25
NDUFA8
AMFR
HIGD2A
KDM1A
hCG_2044799
NUP214
MDH1
BCKDK
EMC8
CLCC1
TMEM126A
SRSF5
MRPL38
SF3B2
TMEM50A
MRPL46
APLP2
TLR8
NDUFV2
NDUFB8
SF3B14
ATAD1
RANBP6
STX16
SLC43A2
ATP6V0C
PET100
HNRNPA3
HSF5
TCERG1
MAN2B2
AP1B1
CEPT1
C10orf11
MRPL23
GALC
MRPL1
SCAMP1
SELT
MRPL17
TOR1AIP1
MBP
MFN2
CHCHD3
MRPL37
ARMC10
SF3B1
SMU1
MTA2
PGAM5
MRPL4
SNX29
SF3B3
NONO
WDR5
VSIG4
SRSF9
TRIM38
RAD50
CLPTM1L
LMNB2
SUN2
SNRPA
NPEPL1
DMXL1
SLC25A35
NDUFB11
SLC25A19
SNRNP70
MRPS28
SRSF7
MT-ND3
CHD4
COX6C
MRC2
GLYR1
NUP153 variant protein
NR3C2
GALNT7
SRSF1
SLC26A11
TIMM23B
CPSF2
MRPL53
SLC25A12
COL6A5
MRPS26
ERH
RAE1
MRE11A
SFPQ
CHERP
SNRPD1
RPA2
AGO1
AOAH
ICMT
NFAM1
MRPL30
MTFP1
PARP10
YIPF3
MRPL32
RBMX
COA3
SNRPF
TMED4
NDUFS4
DDX21
ABHD16A
SNRPE
DHX9
MFF
HIGD1A
RMDN2
TM6SF1
CTCF
C10orf54
HNRNPC
DNMT1
FBL
DHODH
H2AFV
NDUFB6
NDUFS7
C9orf89
HIST2H3PS2
RAB11A
VMP1
HNRPDL
NDUFA2
HIST1H2AJ
GABARAP
HIST1H2BL
MCEMP1
SRRM2
GLIPR1
SYNE1
HIST1H4A
NME1
SF3A3
LMNB1
NUP155
SLC39A7
SEPN1
HSP90AA4P
DNAJC11
CPSF7
ATP5EP2
SNX14
SFRS3
MRPL47
CAMP
GNPTAB
HIST3H2BB
DNAJA3
MATR3
NDUFB5
TOMM5
RALY
NUMA1
ADAR
S100A6
SPOCD1
H2AFY
SDHD
H3F3A
HIST2H3A
PDSS2
HIST1H3A
